Effect of Nebivolol on MIBG Parameters and Exercise in Heart Failure with Normal Ejection Fraction

BACKGROUND: More than 50% of the patients with heart failure have normal ejection fraction (HFNEF). Iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy and cardiopulmonary exercise test (CPET) are prognostic markers in HFNEF. Nebivolol is a beta-blocker with vasodilating properties. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Messias, Leandro Rocha, Ferreira, Aryanne Guimarães, de Miranda, Sandra Marina Ribeiro, Teixeira, José Antônio Caldas, de Azevedo, Jader Cunha, Messias, Ana Carolina Nader Vasconcelos, Maróstica, Elisabeth, Mesquita, Claudio Tinoco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914000/
https://www.ncbi.nlm.nih.gov/pubmed/27096522
http://dx.doi.org/10.5935/abc.20160046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914000/
https://www.ncbi.nlm.nih.gov/pubmed/27096522
http://dx.doi.org/10.5935/abc.20160046

Ejemplares similares